Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans

• Published in: Medical mycology (Oxford) 2016-05, Vol.54 (4), p.428-432
• Main Authors: Longhi, Carline, Santos, Jussevania Pereira, Morey, Alexandre Tadachi, Marcato, Priscyla Daniely, Durán, Nelson, Pinge-Filho, Phileno, Nakazato, Gerson, Yamada-Ogatta, Sueli Fumie, Yamauchi, Lucy Megumi
• Format: Article
• Language: English
• Subjects: Antifungal Agents - chemistry; Antifungal Agents - pharmacology; Biofilms - drug effects; Candida - drug effects; Candida albicans; Drug Resistance, Fungal; Fluconazole - chemistry; Fluconazole - pharmacology; Fusarium - metabolism; Fusarium oxysporum; Metal Nanoparticles - chemistry; Plankton - drug effects; Silver - chemistry; Silver - pharmacology
• ISSN: 1369-3786; 1460-2709
• DOI: 10.1093/mmy/myv036

Silver nanoparticles (AgNPs) have been extensively studied because of their anti-microbial potential. Here, we evaluated the effect of biologically synthesized silver nanoparticles (AgNPbio) alone and in combination with fluconazole (FLC) against planktonic cells and biofilms of FLC-resistant Candida albicans. AgNPbio exhibited a fungicidal effect, with a minimal inhibitory concentration (MIC) and fungicidal concentration ranging from 2.17 to 4.35 μg/ml. The combination of AgNPbio and FLC reduced the MIC of FLC around 16 to 64 times against planktonic cells of all C. albicans. There was no significant inhibitory effect of AgNPbio on biofilm cells. However, FLC combined with AgNPbio caused a significant dose-dependent decrease in the viability of both initial and mature biofilm. All concentrations of AgNPbio, alone or in combination with FLC, were not cytotoxic to mammalian cells. The results highlight the effectiveness of the combination of AgNPbio with FLC against FLC-resistant C. albicans.